D
USANA Health Sciences, Inc. USNA
$14.96 $0.533.67% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

Company Overview

USANA Health Sciences, Inc. is a U.S.-based direct selling company that develops and manufactures nutritional supplements, personal care products, and functional foods. The company operates primarily in the health and wellness industry, with a focus on science-based dietary supplementation and consumer wellness products. USANA generates most of its revenue through direct-to-consumer sales conducted by independent distributors referred to as “Associates,” alongside preferred customers who purchase products directly for personal use. Its primary product categories include nutritional supplements under the USANA Nutritionals line, skincare and personal care products under Celavive, and food and beverage products under brands such as Active Nutrition.

Founded in 1992 by Myron Wentz, a microbiologist and immunologist, USANA evolved from a nutritional supplement company into a globally distributed wellness enterprise with operations spanning multiple international markets. The company has positioned itself around in-house product research, vertically integrated manufacturing, and quality-control systems that support product consistency and regulatory compliance. USANA’s strategic positioning is reinforced by its emphasis on scientific formulation, direct selling infrastructure, and customer retention through recurring wellness consumption.

Business Operations

USANA conducts operations through two primary geographic reporting segments: Asia Pacific and Americas and Europe, as reflected in its SEC filings and annual reports. Revenue is generated primarily from the sale of nutritional supplements and wellness products to Associates and preferred customers. The company maintains manufacturing and research capabilities in the United States, including production facilities designed to support internal quality assurance and supply-chain control. Its vertically integrated operating model enables oversight of formulation, manufacturing, packaging, and distribution activities.

Internationally, USANA operates through subsidiaries and market-specific entities across Asia, North America, Europe, and Oceania. The company has historically derived a substantial portion of revenue from Asian markets, particularly China, where operations are conducted through a modified direct selling and retail model due to local regulatory requirements. USANA also controls and operates several product-focused and regional business entities, including the skincare brand Celavive and nutrition-focused product portfolios tailored for different consumer demographics. The company has also engaged in strategic partnerships and market expansion efforts to strengthen its distributor network and customer acquisition capabilities.

Strategic Position & Investments

USANA’s strategic direction centers on expanding customer acquisition, strengthening digital commerce capabilities, and broadening its health and wellness product portfolio. The company has invested in research and development initiatives aimed at product innovation in nutrition, immune health, sports performance, and personalized wellness. Management has also emphasized investments in digital tools and distributor support systems intended to improve customer engagement and operational efficiency across global markets.

A notable strategic transaction was USANA’s acquisition of Hiya Health Products, LLC, a pediatric nutrition company focused on children’s wellness supplements. This acquisition expanded USANA’s presence in the direct-to-consumer and family health categories. The company has also pursued growth in emerging wellness sectors through product diversification and market-specific expansion strategies. While USANA continues to explore international growth opportunities, particularly in Asia, available public disclosures indicate that the company remains disciplined regarding capital allocation and operational scalability.

Geographic Footprint

USANA is headquartered in Salt Lake City, Utah, and maintains operations across multiple international markets in the Asia-Pacific, North America, and European regions. The company’s largest international exposure has historically been concentrated in Greater China, alongside operations in countries such as South Korea, Malaysia, the Philippines, Australia, and Japan. It also maintains business activities in Canada, Mexico, and select European markets.

The company’s global distribution model relies on local subsidiaries, regional offices, and market-specific compliance structures tailored to differing regulatory environments. USANA’s international footprint provides exposure to both developed and emerging consumer wellness markets, with Asia representing a significant contributor to consolidated net sales according to recent public filings. Its operational influence is supported by regional logistics infrastructure, localized marketing programs, and multilingual distributor networks.

Leadership & Governance

USANA was founded by Dr. Myron Wentz, whose scientific background helped shape the company’s emphasis on nutritional research and product quality. The company is publicly traded on the New York Stock Exchange under the ticker USNA and operates under a corporate governance structure overseen by a board of directors and executive leadership team. Management has consistently emphasized long-term customer retention, product science, operational discipline, and international market development as central components of corporate strategy.

Key executives include:

  • Jim Brown – President and Chief Executive Officer
  • Doug Hekking – Chief Financial Officer
  • Brent Neidig – Chief Commercial Officer
  • Dr. John E. Cuomo – Executive Director of Product Innovation and Technology
  • Kevin Guest – Executive Chairman

Leadership communications in public filings and investor materials consistently emphasize scientific credibility, distributor engagement, geographic diversification, and disciplined expansion within the global health and wellness sector.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $230.36
B
AAPL NASDAQ $319.97
B
AVGO NASDAQ $357.90
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $107.14
A
Top Financial Stocks
See All »
B
B
JPM NYSE $358.64
B
V NYSE $375.07
Top Health Care Stocks
See All »
B
LLY NYSE $1,149.36
B
JNJ NYSE $275.23
B
ABBV NYSE $256.46
Top Real Estate Stocks
See All »
B
PLD NYSE $137.34
B
EQIX NASDAQ $1,035.98